AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Plant-based vaccines getting closer to the market.
2003 AUG 20 - (NewsRx.com & NewsRx.net) -- Plant-based vaccines are getting closer to commercial reality, according to a report in the International Journal for Parasitology.
"Plant systems are reviewed with regard to their ability to express and produce subunit vaccines. Examples of different types of expression producing a variety of vaccine candidates are illustrated. Many of these subunit vaccines have been purified and shown to elicit an immune response when injected into animal models," researchers in the United States report.
"This review also includes vaccines that have been administered orally in a non-purified form as a food or feed product," stated Stephen J. Streatfield and John A. Howard at ProdiGene, Inc. in Texas. "Cases are highlighted which demonstrate that orally delivered plant-based vaccines can elicit immune responses and, in some case studies, confer protection. Examples are used to illustrate some of the ...
- Genome-based vaccines reviewed.
- Newspaper article from: World Disease Weekly December 28, 2004 700+ words
...genome-based vaccines in a recent issue of the International Journal of Medical...study in the International Journal of Medical...Genome-based vaccines. Int J Med...information for the International Journal of Medical...
- Examine the Fundamental Science and the Latest Developments in...
- Press release article from: M2 Presswire July 3, 2009 700+ words
...Latest Developments in Carbohydrate-Based Vaccines(C)1994-2009 M2 COMMUNICATIONS...Ltd's new report "Carbohydrate-Based Vaccines and Immunotherapies" to their offering...latest developments in carbohydrate-based vaccines. The relatively new field of glycoimmunology...
- Research and Markets: Examine the Fundamental Science and the Latest...
- Press release article from: Business Wire July 3, 2009 700+ words
...Ltd's new report "Carbohydrate-Based Vaccines and Immunotherapies" to their offering...latest developments in carbohydrate-based vaccines. The relatively new field of glycoimmunology...antigenic determinants. Carbohydrate-Based Vaccines and Immunotherapies comprehensively...
- DNA-based vaccines being developed to battle bioterrorism.
- Newspaper article from: Drug Week February 27, 2004 700+ words
...applying gene transfer technology to DNA-based vaccines and immune targeting related to bioterrorism...ready for human application, DNA-based vaccines appear to be among the most promising...in the face of bioterrorism: DNA-based vaccines and immune targeting. Expert Opin...
- ISCOM-based vaccines show promise for cancer immunotherapy.
- Newspaper article from: Biotech Week April 28, 2004 700+ words
...amp; NewsRx.net) -- ISCOM-based vaccines show promise for cancer immunotherapy...immunogen. Here we illustrate that ISCOM-based vaccines represent an attractive modality for...published their study in Vaccine (ISCOM based vaccines for cancer immunotherapy. Vaccine...
- Peptide-based vaccines for cancer immunotherapy reviewed.
- Newspaper article from: Immunotherapy Weekly April 21, 2004 700+ words
...net) -- Scientists review peptide-based vaccines for cancer immunotherapy in a recent...concerning the efficacy of peptide-based vaccines for cancer immunotherapy," said Joeli...Opinion on Biological Therapy (Peptide-based vaccines for cancer immunotherapy. Expert Opin...
- Bioject Initiates Human Clinical Trials Delivering DNA-Based Vaccines for The...
- Press release article from: PR Newswire March 16, 1999 700+ words
...optimal route of delivery for DNA-based vaccines. "Bioject is committed to developing...used to enhance the delivery of DNA-based vaccines for the treatment of cancer, a promising...products to enhance delivery of DNA-based vaccines. Such forward-looking statements...
- Tumor cell-based vaccines are potent activators of CD4+ T lymphocytes.
- Newspaper article from: Vaccine Weekly July 28, 2004 700+ words
...MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4...specific CD4+ T cells. The cell-based vaccines consist of MHC class I+ tumor cells...MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4...
Source: HighBeam Research, Plant-based vaccines getting closer to the market.